Abstract
BackgroundPatients with cancer are at high risk for severe COVID-19 disease and mortality1; however, patients on active cancer treatment, including immune checkpoint inhibitors (ICI), were excluded from COVID19 vaccine trials.2...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have